As it is difficult to distinguish rosacea-like dermatitis from acne vulgaris, which is not related to EGFR inhibitors, the management of EGFR inhibitor-induced skin rash plays an important role during cancer treatment. This evidence concerns the gene EGFR and Skin rash.